DroneShield Stock: Insider Sell‑Offs, CEO Shake‑Up and New Share Issue Roil ASX:DRO (28–29 November 2025)

DroneShield’s share price has steadied around the A$2 mark after one of the most dramatic two weeks in recent ASX history – but the news flow on 28–29 November 2025 shows that the governance storm is far from over.

29 November 2025

ASX:DRO · OTC:DRSHF

DroneShield Stock Skyrockets 40%: What’s Behind the Surge and What’s Next?

DroneShield Stock Today (Germany: DRH, U.S.: DRSHF) — 13 November 2025: Shares Slide After Insider Sales; Company Responds to ASX Query

DroneShield’s stock is under pressure across European trading after a dramatic sell‑off on the Australian market tied to insider transactions. Bloomberg reported that CEO Oleg Vornik sold A$49.5 million worth of shares between Nov 6–12, part of performance options that vested on Nov 5. The ASX‑listed shares slumped about 31% intraday on Thursday in Sydney. Bloomberg Law

13 November 2025

ASX:DRO·Drone Technology·OTC:DRSHF·Stock Market

DroneShield Stock Today (Germany: DRH, U.S.: DRSHF) — 13 November 2025: Shares Slide After Insider Sales; Company Responds to ASX Query

TechStock² Updates

Ambev Shares Slide 0.7%, 30 Million Shares Test 31.6% Margin Rebound

Coeur Mining Stock Falls 4.9%, Erasing $1.1 Billion as Metals Slide

B2Gold Reports Masbate Fatality After Stock Falls 2.9%; Production Continues

IREN Shares Drop 12.5% With $4 Billion AI Expansion Pushing Up Against $6.4 Billion Financing Hurdle

NVIDIA Sheds 4.6% and Loses $252 Billion in Value as Margin Concerns Emerge Over Memory Prices

SpaceX Shares Edge Up 0.5% with $1.86 Trillion Value as Quarterly Capex Hits $18.4 Billion

Intel Shares Drop 2.9%, Remain 5.8% Under $95 Offering as Company Delivers 25% Revenue Gain

PG&E Shares Drop 7.5%, Wiping Out $3 Billion After Delay to California Wildfire Shield

DraftKings Faces $67.6 Million Loss on $13.1 Billion U.S. Open Betting Volume

Netflix Sets September 17 Return for Stranger Things: Tales From ’85, Eyes $3 Billion in Ad Revenue

Investment Disclaimer